Nasal nitric oxide in the inferior turbinate surface decreases with intranasal steroids in allergic rhinitis: A prospective study

[1] Arnal JF, Didier A, Rami J, M’Rini C, Charlet JP, Serrano E, et al.

Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy

1997;27:358–62.

[2] Takeno S, Osada R, Furukido K, Chen JH, Yajin K. Increased nitric

oxide production in nasal epithelial cells from allergic patients — RTPCR analysis and direct imaging by a fluorescence indicator: DAF-2

DA. Clin Exp Allergy 2001;31:881–8.

[3] Struben VM, Wieringa MH, Feenstra L, de Jongste JC. Nasal nitric

oxide and nasal allergy. Allergy 2006;61:665–70.

[4] Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways

inflammatory diseases. Inflamm Res 2007;56:58–69.

[5] Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H,

et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive

review. Chest 2010;138:682–92.

[6] Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg

JO, et al. An official ATS clinical practice guideline: interpretation of

exhaled nitric oxide levels (FENO) for clinical applications. Am J

Respir Crit Care Med 2011;184:602–15.

[7] Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J,

Anggaard A, et al. High nitric oxide production in human paranasal

sinuses. Nat Med 1995;1:370–3.

[8] Takeno S, Yoshimura H, Kubota K, Taruya T, Ishino T, Hirakawa K.

Comparison of nasal nitric oxide levels between the inferior turbinate

surface and the middle meatus in patients with symptomatic allergic

rhinitis. Allergol Int 2014;63:475–83.

[9] Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A,

et al. World Health Organization; GA(2)LEN; AllerGen. Allergic

rhinitis and its impact on asthma (ARIA) 2008 update. Allergy

2008;63(s86):8–160.

[10] Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi

H, et al. Japanese Society of Allergology. Japanese guidelines for

allergic rhinitis 2017. Allergol Int 2017;66:205–19.

[11] Takeno S, Okabayashi Y, Kohno T, Yumii K, Hirakawa K. The role of

nasal fractional exhaled nitric oxide as an objective parameter independent of nasal airflow resistance in the diagnosis of allergic rhinitis.

Auris Nasus Larynx 2017;44:435–41.

[12] American Thoracic Society, European Respiratory Society. ATS/ERS

recommendations for standardized procedures for the online and

offline measurement of exhaled lower respiratory nitric oxide and

nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912–30.

[13] Qian W, Djupesland PG, Chatkin JM, McClean P, Furlott H, Chapnik

JS, et al. Aspiration flow optimized for nasal nitric oxide measurement.

Rhinology 1999;37:61–5.

[14] Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot

H, et al. Nasal nitric oxide: longitudinal reproducibility and the effects

of a nasal allergen challenge in patients with allergic rhinitis. Allergy

2007;62:378–84.

[15] Bautista AP, Eisenlohr CP, Lanz MJ. Nasal nitric oxide and nasal

eosinophils decrease with levocetirizine in subjects with perennial

allergic rhinitis. Am J Rhinol Allergy 2011;25:383–7.

[16] Kharitonov SA, Rajakulasingam K, O’Connor B, Durham SR, Barnes

PJ. Nasal nitric oxide is increased in patients with asthma and allergic

rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin

Immunol 1997;99:58–64.

[17] Baraldi E, Azzolin NM, Carra` S, Dario C, Marchesini L, Zacchello F.

Effect of topical steroids on nasal nitric oxide production in children

with perennial allergic rhinitis: a pilot study. Respir Med 1998;92:558–

61.

[18] Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D,

et al. Efficacy of mometasone furoate nasal spray for nasal symptoms,

quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients

with perennial allergic rhinitis. Allergy Asthma Proc 2012;33:e9–16.

[19] Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and

objective markers of treatment response in patients with seasonal

allergic rhinitis. Ann Allergy Asthma Immunol 2000;85:111–4.

[20] Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy

with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp

Allergy 2001;31:61–8.

[21] Andersson JA, Cervin A, Lindberg S, Uddman R, Cardell LO. The

paranasal sinuses as reservoirs for nitric oxide. Acta Otolaryngol

2002;122:861–5.

[22] Shusterman DJ, Weaver EM, Goldberg AN, Schick SF, Wong HH,

Balmes JR. Pilot evaluation of the nasal nitric oxide response to

humming as an index of osteomeatal patency. Am J Rhinol Allergy

2012;26:123–6.

[23] Williamson PA, Vaidyanathan S, Clearie K, Stewart M, Lipworth BJ.

Relationship between fractional exhaled nitric oxide and nasal nitric

oxide in airways disease. Ann Allergy Asthma Immunol

2010;105:162–7.

[24] Jeong JH, Yoo HS, Lee SH, Kim KR, Yoon HJ, Kim SH. Nasal and

exhaled nitric oxide in chronic rhinosinusitis with polyps. Am J Rhinol

Allergy 2014;28:e11–6.

...